Zhejiang HISUN Pharmaceutical Co., Ltd. announced the progress of its fourth share repurchase through centralized bidding. The repurchase plan was approved by the board of directors and the supervisory board on May 12, 2025, with an implementation period from May 12, 2025, to May 11, 2026. The expected repurchase amount is between 50 million yuan and 100 million yuan, intended for employee stock ownership plans or equity incentives. As of the end of September 2025, the company has repurchased a total of 5,535,000 shares, accounting for 0.46% of the total share capital, with a total payment amount of 50,891,385 yuan, and the actual repurchase price range is from 8.92 yuan/share to 9.40 yuan/share